Merck (MRK) reportedly cutting workforce at the Gardasil plant, citing falling global demand, according to reports

Merck (MRK) reportedly cutting workforce at the Gardasil plant, citing falling global demand, according to reports.

Merck's decision to cut its workforce at the Gardasil plant highlights the challenges posed by declining global demand for its vaccine. This move is a potential signal of broader issues within the pharmaceutical sector, possibly impacting investor sentiment towards Merck and its peers. Watch for implications on stock performance and any strategic shifts in the company or industry as they respond to changing market dynamics.